Overproduction and Characterization of Recombinant Soluble Trypanosoma brucei Phospholipase A2

Overproduction and Characterization of Recombinant Soluble Trypanosoma brucei Phospholipase A2

ABSTRACT Trypanosoma brucei phospholipase A2 (TbPLA2) is a validated drug target but the difficulty in expressing its soluble recombinant protein has limited its exploitation for drug and vaccine development for African and American trypanosomiases. We utilized recombinant deoxyribonucleic acid (DNA...

Full description

Saved in:

Bibliographic Details
Main Authors:	Oluwafemi Abiodun Adepoju, Daniel Quinnell, Harshverdhan Sirohi, Emmanuel Amlabu, Abdullahi Balarabe Sallau, Abdulrazak Ibrahim, Sunday Ene‐Ojo Atawodi, Mohammed Nasiru Shuaibu, Geoffrey Chang, Emmanuel Oluwadare Balogun
Format:	Article
Language:	English
Published:	Wiley-VCH 2025-03-01
Series:	Engineering in Life Sciences
Subjects:	kinetoplastids neglected tropical diseases recombinant DNA technology Trypanosoma brucei phospholipase A2 trypanosomiasis
Online Access:	https://doi.org/10.1002/elsc.70005
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

African animal trypanocide resistance: A systematic review and meta-analysis
by: Keneth Iceland, Kasozi, et al.
Published: (2023)

Metabolomics study of 3-O-p-(Z/E)-coumaroyltormentic acid-treated Trypanosoma brucei brucei
by: Lúcia Mamede, et al.
Published: (2025-08-01)

Stumpy forms are the predominant transmissible forms of Trypanosoma brucei
by: Jean Marc Tsagmo Ngoune, et al.
Published: (2025-06-01)

Epidemiology of Trypanosomiasis in Wildlife—Implications for Humans at the Wildlife Interface in Africa
by: Keneth Iceland, Kasozi, et al.
Published: (2023)

Discovery of unique mitotic mechanisms in Paradiplonema papillatum
by: Bungo Akiyoshi, et al.
Published: (2025-08-01)

Human phospholipases A2: a functional and evolutionary analysis
by: I. I. Turnaev, et al.
Published: (2023-01-01)

Itraconazole-resistant Candida auris with phospholipase, proteinase and hemolysin activity from a case of vulvovaginitis
by: Dharmendra Kumar, et al.
Published: (2015-04-01)

IL-4Rα signalling influences behavioural and immune responses in Trypanosoma brucei-infected mice: Evidence for iloprost as a neuroprotective agent
by: OS Olaolu, et al.
Published: (2025-12-01)

Systematic Review and Meta-Analysis on Human African Trypanocide Resistance
by: Keneth Iceland, Kasozi, et al.
Published: (2023)

Effect of plasma lipoprotein-associated phospholipase A<sub>2</sub> levels on structure and function of heart in patients undergoing maintenance hemodialysis
by: WANG Yun-qian, et al.
Published: (2016-01-01)

Systematic Review and Meta-Analysis on Knowledge Attitude and Practices on African Animal Trypanocide Resistance
by: Keneth Iceland, Kasozi, et al.
Published: (2023)

N-aldehyde-modified phosphatidylethanolamines generated by lipid peroxidation are robust substrates of N-acyl phosphatidylethanolamine phospholipase D
by: Reza Fadaei, et al.
Published: (2025-07-01)

Proteomics Analysis of the Regulatory Mechanism of the Calcium-Independent Phospholipase A2 Activity of Peroxiredoxin 6 on Beef Tenderization
by: LIU Jitong, WANG Xinyi, ZHANG Yimin, ZHU Lixian, LIANG Rongrong, MAO Yanwei
Published: (2025-06-01)

Effects of combined therapy with atorvastatin and polyunsaturated omega-3 fatty acids on lipid profile, lipoprotein-associated phospholipase A2 and thromboxane
by: G. F. Piksina, et al.
Published: (2010-10-01)

Diagnóstico de tripanosomiasis americana en estudiantes de la Escuela Latinoamericana de Medicina
by: Jorge Pável Delgado La O', et al.

Nuclear inositides
by: C D'Santos, et al.
Published: (2009-12-01)

Expression and significance of phospholipase A2 receptor and thrombospondin type-1 domain 7A in idiopathic membranous nephropathy
by: LI Fei, et al.
Published: (2019-01-01)

Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody–Positive Primary Membranous Nephropathy
by: Brad H. Rovin, et al.
Published: (2024-09-01)

Secretory phospholipase A2: a biomarker of inflammation in autoimmune, bacterial and viral diseases
by: S. P. Urazov, et al.
Published: (2022-07-01)

An Update on African Trypanocide Pharmaceutics and Resistance.
by: Keneth Iceland, Kasozi, et al.
Published: (2023)

Parasitic infections and the development of endomyocardial fibrosis: systematic review of case reports and case series
by: Abel Aizeque, et al.
Published: (2025-08-01)

Evaluation of In Vitro Activity of Essential Oils against Trypanosoma brucei brucei and Trypanosoma evansi
by: Nathan Habila, et al.
Published: (2010-01-01)

Recent progress in the pathogenesis of membranous nephropathy
by: He Zhi-hua, et al.
Published: (2022-05-01)

Trypanosoma dionisii in China: ecology and tentative epidemiology
by: Qin Liu, et al.
Published: (2025-07-01)

Population genetics of Glossina palpalis gambiensis in the sleeping sickness focus of Boffa (Guinea) before and after eight years of vector control: no effect of control despite a significant decrease of human exposure to the disease
by: Kagbadouno, Moise S, et al.
Published: (2024-02-01)

Role of compositional disorders in phospholipids in the pathogenesis of cytomegalovirus infection in the gestation period
by: N. A. Ishutina
Published: (2015-05-01)

Platelet-activating Factor–Acetyl Hydrolase is Associated with Dysregulated Expression of <i>Nrf2</i>-NQO1 Pathway in Metabolic Syndrome
by: Seema Garg, et al.
Published: (2025-05-01)

Cytological profiling of trypanocidal principles from Aloe barbadensis and Taraxacum officinale
by: Pearl Ihuoma Akazue, et al.
Published: (2025-05-01)

Research progresson correlation of PLA2R1 and HLA gene polymorphisms with susceptibility toidiopathic membranous nephropathy
by: XIE Da-xing, et al.
Published: (2019-01-01)

PLA2R-associated membranous nephropathy associated with renal clear cell carcinoma: one case report
by: Xu Xiao-chang, et al.
Published: (2021-01-01)

Molecular and Genetic Analysis of the Increased Number of Genes for <i>Trypanosoma cruzi</i> Microtubule Associated Proteins in the Class Kinetoplastida
by: Martin A. Winkler, et al.
Published: (2025-05-01)

Managing African animal trypanosomiasis in Benin: Knowledge, attitudes, and practices of cattle owners in the West Atacora zone
by: Yao Akpo, et al.
Published: (2025-06-01)

Search for and functional annotation of multi-domain PLA2 family proteins in flatworms
by: M. E. Bocharnikova, et al.
Published: (2025-01-01)

Clinicopathological characteristics of idiopathic membranous nephropathy in 65 elderly patients
by: LIU Wen-xue, et al.
Published: (2017-01-01)

Study on predictors for treatment efficacy of rituximab in patients with PLA2R-negative primary membranous nephropathy
by: XU Lili, HU Xiaofan, LI Hao, WANG Weiming
Published: (2025-06-01)

Efficacy and safety of obinutuzumab in primary membranous nephropathy: a real-world retrospective study
by: Xi Cheng, et al.
Published: (2025-08-01)

Distinctive biochemical properties of the μ-opioid receptor-corticotropin- releasing factor CRF1 receptor heterotetramer
by: William N. Sanchez, et al.
Published: (2025-09-01)

Topical glucocorticoids and the skin-mechanisms of action: an update
by: A. Ahluwalia
Published: (1998-01-01)

Understanding Sex-biases in Kinetoplastid Infections: Leishmaniasis and Trypanosomiasis
by: Olivia Battistoni, et al.
Published: (2025-01-01)

Current data on the effectiveness of gliclazide and molecular mechanisms of action of the drug
by: Nina A. Petunina, et al.
Published: (2020-12-01)